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yocarditis is associated with a broad range of pathological immune processes in the heart, 1 and its clinical presentation can vary substantially. Acute myocarditis, for example, can present with arrhythmias, syncope, or even sudden cardiac death, but it can also progress slowly into a phenotype of inflammatory dilated cardiomyopathy. 2 Cardiac magnetic resonance (CMR) is now accepted as a sensitive method for the work-up of suspected myocarditis, 3 for example, in the setting of acute or chronic heart failure. 4 In addition to the evaluation of cardiac function, CMR allows for tissue characterization by means of the late gadolinium enhancement approach, which probes tissue viability, thereby detecting inflammatory lesions when accompanied by irreversible tissue damage. 5, 6 CMR can also visualize tissue edema through T 2 -weighted imaging 7 or more recently by T 2 mapping. 8 However, these CMR applications are not specific for a particular type of tissue injury, as necrosis and edema can also develop in the setting of ischemia, for example, in acute coronary syndrome. In addition, these CMR methods do not provide information on the extent and timing of inflammatory cell infiltrations during the disease process. A noninvasive imaging strategy that detects inflammatory cells and which is not based on secondary tissue alterations (such as necrosis and edema) is therefore highly desirable for a more detailed characterization of myocarditis. Ideally, such a technique should exclusively detect inflammation and be able to do so before alterations in tissue properties even occur. To this end, we investigated a novel CMR approach that is based on the ability of infiltrating inflammatory cells to phagocyte fluorine-containing particles and enables the noninvasive visualization of inflammatory lesions. March 2013
Because fluorine-19 ( 19 F) is virtually absent in animals and humans, 19 F MRI offers the unique possibility to detect an injected substance that contains 19 F without any background signal and with 85% of the sensitivity of 1 H MRI. 9 This theoretically results in a very high contrast-to-noise ratio and a high specificity of the signal, as any 19 F signal detected in the body can be unambiguously attributed to the injected 19 F. As the signal received by an MR volume coil is directly proportional to the amount of 19 F nuclei present in the tissue, the signal can be related to a reference of known 19 F concentration, which renders this technique fully quantitative. 10 In this regard, it differs from indirect contrast agents that are based on relaxation time alterations (such as iron oxide or gadolinium), which often have a nonlinear dose-signal response at higher concentrations. 11 Finally, the 19 F signal can be fused with conventional 1 H images for anatomic coregistration. 12 As demonstrated by several groups, 13 19 F MRI is able to detect macrophages after intravenous injection of perfluorocarbons (PFC) emulsions in several disease processes, such as pneumonia, 14 heterotopic acute cardiac allograft rejection in rat and in mouse models, 15, 16 and in healing after myocardial infarction in mice. 17 The goal of the current study was, therefore, to characterize the performance of 19 F-CMR for the specific detection of inflammatory cells in a mouse model of CD4 + T cell-mediated experimental autoimmune myocarditis (EAM). 18 EAM tends to progress into an inflammatory dilated cardiomyopathy phenotype along with the development of increased interstitial fibrosis. In the EAM model, quantifiable stages of acute myocarditis and inflammatory dilated cardiomyopathy can be distinguished. 19 EAM thus seems to be an ideal model to test the hypothesis that 19 F-CMR is able to detect the inflammatory cells recruited to the myocardium of EAM mice both noninvasively and quantitatively. In the setting of an inflammatory process, currently available MR methods allow for the measurement of necrosis, edema, fibrosis, and alterations of regional or global function. The proposed 19 F-based CMR approach may provide complementary information related to the disease process itself, that is, the amount and timing of myocardial infiltration by inflammatory cells, which could advance our understanding of the inflammatory disease process and may also enable an early detection of the disease.
Methods

Experimental Autoimmune Myocarditis Model
All animal experiments performed in this study were approved by the local and institutional animal ethics committee. A total of 23 male BALB/c mice (29.4±3.2 g) entered the study (Figure 1 ). To induce EAM, 17 mice were injected subcutaneously with 150 µg of αMyHC peptide (alpha myosin heavy chain, Ac-RSLKLMATLFSTYASADR-OH; Caslo, Lyngby, Denmark) emulsified 1:1 with complete freund's adjuvant (Difco, Franklin Lakes, NJ) on days 0 and 7, as previously described. 20 In the EAM model, immunization results in acute myocarditis that peaks ~21 days after immunization. Inflammation resolves slowly thereafter, whereas the number of cardiac fibroblasts progressively increases on follow-up. 21 Six mice were sham-immunized with saline/complete freund's adjuvant and served as controls.
In Vivo Inflammatory Cell Labeling
The main 19 F in vivo cellular labeling agent used in this study in 9 EAM mice was an emulsion of a linear polymer PFC (V-Sense 1000H, Celsense, Pittsburgh, PA) that contains 1.67×10 24 19 F atoms per liter. Furthermore, 5 additional EAM mice were injected with a dual-labeled PFC that also contains fluorescein isothiocyanate (FITC) for postmortem fluorescent microscopy and flow-cytometry analyses. This dual-labeling FITC-PFC is known to remain stable without dissociation of its components for more than a week in cell cultures, whereas it is also characterized by a slightly decreased labeling efficiency versus the nonfluorescent compound (unpublished data, provided by the manufacturer) and was thus not used in MR signal calculations. The PFC emulsion was administered through the tail vein at a dose of 200 µL (6.8 mL/kg body weight) on both day 19 and 20 after immunization (Figure 1 ). Three EAM mice served as controls and were injected with saline instead of PFC before 19 F-CMR.
H and 19 F-CMR
On day 21 after immunization, animals underwent isoflurane anesthesia. The animals were placed on top of a custom-designed 18-mmdiameter quadrature surface coil tunable to both the 1 H and 19 F frequencies (400.2 and 376.6 MHz, respectively). The body temperature was monitored and kept constant at 37.0±0.5°C. "A respirationgated and ECG-triggered segmented k-space gradient echo sequence (repetition time (TR) 3.8 ms, echo time (TE) 1.9 ms, signal averages 4, matrix 128×128, field of view 30×30 mm 2 , slice thickness 2 mm, total acquisition time ≈5 minutes) was used (9.4T spectrometer, Varian, Palo Alto, CA) to obtain 3 1H short-axis images of the heart. At the anatomic location of the central slice, a prospectively gated gradientecho cine imaging series (TR=10 ms, TE=1.9 ms, 14 frames, signal averages 4, matrix 128×128, slice thickness 1 mm, total acquisition time ≈5 minutes) was also acquired. Next, at the location of the 3 1H short-axis images, a turbo spin echo sequence (TR=500 ms, TE=3.7 ms; echo-train length 4, signal averages 240, matrix 64×64, total acquisition time 32 minutes) was used for the 19F-CMR acquisitions. After the in vivo CMR acquisitions, the animals were euthanized with pentobarbital and the hearts were perfused with saline, excised and fixed in formalin for postmortem analysis. To investigate whether the in vivo 19F signal was related to the proximity of RF coil to the anterior wall of the heart, ex vivo high-resolution 1H-and 19F-CMR of the hearts of 7 mice ( Figure 1A ) placed with their apex closest to the RF coil was performed. A 3-dimensional gradient-echo sequence (TR=7.0 ms, TE=3.6 ms, signal averages 256, matrix 128×128×64, field of view 15×15×15 mm 3 , acquisition time 4 hours 4 minutes), which had better spatial coverage but inferior sensitivity per unit of time than the in vivo sequence, was used."
All image analyses were performed on the unprocessed modulus images in Matlab (Mathworks, Natick, MA). The total myocardial volume with elevated 19 F signal (Vol inflam ) was determined as follows (for details, see Figure I in the online-only Data Supplement): first, the heart and the liver were segmented on the anatomic 1 H images. Next, the liver was segmented in the corresponding 19 F images, whereas the 19 F noise level was determined as the SD of the 19 F signal intensity of a large region outside the mouse body. Finally, the voxels of the 19 F images that were in the region of the heart but not in the liver and had a 19 F signal 7× higher than the noise were added up to Vol inflam, and their average signal-to-noise ratio (SNR) was calculated. This threshold for detection of 19 F-positive pixels was applied to avoid pixel selection in minor motion-related ghosts and the isoflurane anesthetic that were consistently lower in signal than this threshold. The 19 F signal integral was then calculated as the product of Vol inflam and the SNR. To study the prevalent spatial distribution of the 19 F signal in EAM, 6 the in vivo 19 F signal distribution of each animal was classified in analogy to the standard myocardial segmentation model, 22 but without the apical segment and with 6 additional segments covering the right ventricle. A segment was defined positive if ≥25% of pixels of the segment showed an elevated 19 F signal. The left ventricular (LV) area shortening fraction was calculated from end-diastolic and end-systolic 1 H cine images acquired at the midventricular level (Argus, Siemens Healthcare, Erlangen, Germany) as a rough estimate for global LV systolic function. A dilution series of the PFC in agar was created to ascertain the minimum 19 F atomic concentration needed for its detection with the in vivo pulse sequence at a given SNR=2.
Histology, Immunohistochemistry, and Immunofluorescence
The inflammatory cell infiltrations of the excised hearts mentioned above were analyzed in paraffin sections ( Figure 1 ). Adjacent heart sections were treated differently to determine (1) the myocarditis severity score with hematoxylin-eosin (HE), (2) the cell type in the inflammatory cell area by immunohistochemistry, and (3) the presence of PFC-FITC in inflammatory cells by immunofluorescence.
The myocarditis severity was scored as described previously 19 on the HE-stained heart sections using a semiquantitative scale: 0, no inflammatory infiltrates; 1, small foci of inflammatory cells between myocytes; 2, larger foci of >100 inflammatory cells; 3, >10% of a cross-section involved; 4, >30% of a cross-section involved. 19 Correlations were calculated between this histological disease score and the 19 F SNR, Vol inflam , the signal integral, and the midventricular LV area shortening fraction.
For immunohistochemistry, rabbit antimouse CD45 1:250 (BD Bioscience, Switzerland) and rat antimouse F4/80 1:150 (BMA Biomedicals, Switzerland) antibodies were used to detect inflammatory bone marrow-derived cells and macrophages, respectively. Diaminobenzidine was used as the chromogen. For immunofluorescence, rat-anti-F4/80 1:100 (Abcam, Boston, MA) and monoclonal rabbit-anti-FITC 1:100 (Invitrogen, Switzerland) were used to detect macrophages and PFC-FITC, respectively. The fluorochrome-conjugated secondary antibodies used were Alexa 546 goat-anti-rat 1:600 and Alexa 488 chicken-anti-rabbit, respectively (Invitrogen). Nuclei were detected with DAPI (4',6-diaminidino-2-phenylindole, Roche, Switzerland).
Flow Cytometry
Hearts from FITC-PFC-injected EAM mice ( Figure 1C ) were excised at day 21 after immunization, then perfused with cold PBS, dissected into small pieces and digested for 50 minutes at 37°C in collagenase blendzyme (Liberase; Roche, Switzerland). Single-cell suspensions were obtained by straining through a 70 µm nylon mesh (BD Biosciences). Cells were washed twice with 50 mL fluorescenceactivated cell sorter (FACS) buffer (1% FCS, 1 mmol/L EDTA in PBS, all from Gibco, Switzerland) and incubated 30 minutes on ice with the appropriate combination of fluorochrome-or biotin-conjugated antibodies. The antibodies used were fluorochrome-conjugated antibodies: anti-CD45-PE, anti-CD11b-APC, anti-CD11c-APC, anti-CD4-APC, anti-Gr-1-PE (all from BD Bioscience); and biotin-conjugated antibodies: anti-F4/80 (Cedarlane, Burlington, ON, Canada), anti-CD45 (BD Bioscience). Streptavidin-APC (BD Bioscience) was used to detect biotin-conjugated antibodies. Cells were profiled with the FACS-Canto analyzer (BD Bioscience) and data were analyzed with FlowJo software (Tree Star, Ashland, OR).
Statistical Analyses
All statistical analyses were made in SPSS Statistics 20.0 (IBM, Armonk, NY), The groups of EAM and control mice were compared with unpaired 2-tailed Student's t tests. Correlations of the 19 F-SNR, Vol inflam , 19 F signal integral, and LV area shortening with the disease severity score were calculated with Spearman ranked correlation. P<0.05 was considered significant.
Results
EAM was induced in 17 animals as confirmed in 11 animals by histology (Figure 1, experiments A, C, D) . In the 3 animals used for flow cytometry, histology was not applicable, whereas in another 3 animals histology was not performed for technical/logistical reasons. No adverse effects were observed after PFC injections in any of the experiments.
Detection of EAM by 19 F-CMR
In vivo CMR of PFC-injected mice with myocarditis demonstrated 19 F signal in all 9 animals ( Figure 2 , solid arrows).
19
F-positive regions in the heart were well defined and showed a predilection of the subepicardial layers of the myocardium as illustrated in Figure 2C and 2D (inferior LV wall). Threedimensional high-resolution ex vivo CMR confirmed the predominantly subepicardial distribution of the 19 
F signal (n=10, from experiments A [n=7] and B [n=3]
). An example is shown in Figure 3 .
In the in vivo experiments, a 19 F signal was furthermore observed in the liver (Figure 2, dotted arrows) and was attributed to PFC phagocytosed by Kuppfer cells. 23 This liver signal Time advances from left to right and is indicated in days, whereas a number of animals X that undergoes a certain procedure is given as n=X. A, For the principal investigation, n=9 mice were immunized to develop experimental autoimmune myocarditis (EAM) and were subsequently injected with perfluorocarbon (PFC). They were then euthanized, after which n=7 excised mouse hearts received ex vivo cardiac magnetic resonance (CMR), histology (histo) and immunohistology (immuno). B, n=6 mice served as healthy controls (disease grade 0). They were sham-immunized but received PFC injections. They were also used in the correlation calculations shown in Figure 8 . C, n=5 mice received the dual-labeled fluorescein isothiocyanate (FITC)-PFC instead of PFC. n=2 of these mice were used for colocalization of the PFC with macrophages through immunofluorescence (fluo), whereas n=3 animals were used for flow cytometry to investigate which type of immune cells in the myocardium had phagocytized the PFC. D, n=3 mice were immunized to induce EAM but were injected with saline instead of PFC to assure that there were no fluorine-19 magnetic resonance signals in the heart if no PFC was injected.
was also observed in the 6 sham-immunized PFC-injected control animals without myocarditis ( Figure 2F ), whereas no 19 F signal was detected in their hearts.
A diffuse low-intensity 19 F signal that was ascribed to the anesthetic isoflurane was observed in the subcutaneous fat in most animals, but was usually removed by the processing threshold. The SNR of the 19 F signal regions in the heart was 25±19 (range: 4-60), whereas Vol inflam was 46±46 mm 3 (range, 7-144 mm). 3 The distribution of the average 19 F signal (n=11, experiments A, C) was located predominantly in the basal anterolateral part of the heart, whereas the 
Colocalization of Inflammatory Cells and 19 F Signal in the Inflamed Myocardium
Immunohistochemistry confirmed the presence of CD45 and F4/80-positive inflammatory cells in the heart at locations where the 19 F signal was observed by CMR ( Figure 5 ). In the mice injected with the dual-labeled emulsion, fluorescent microscopy demonstrated colocalization of the F4/80 marker (macrophage) and FITC (PFC) signal ( Figure 6 ) and thus F4/80-positive macrophages were identified as a source of the 19 F signal.
Incorporation of PFC Emulsion in Different Cells Infiltrating the Myocardium
To determine which cell types were able to incorporate the PFC-FITC emulsion in the inflammatory environment of the heart, flow-cytometry analysis of FITC (which corresponded to PFC) was performed on nonmyocyte singlecell populations isolated from the myocardium of the EAM mice that were injected with the PFC-FITC emulsion. FITC was detected in CD45+/CD11b+ monocytes, CD45+/F4/80+ macrophages, CD45+/CD11c+ dendritic cells, and CD45+/ Gr-1+ granulocytes. Although this EAM model is known to be mediated by CD4+ lymphocytes, 19 no FITC was detected in CD45+/CD4+ T-lymphocytes ( Figure 7) .
Correlation of Histological Disease Score and CMR Parameters
A significant correlation was found between the histological disease severity score and the SNR of the 19 signal integral (r s =0.96; P<0.001), as demonstrated in Figure 8 . In contrast, the midventricular LV area shortening fraction, which was used as an estimate of LV systolic function, did not correlate with the disease score (r s =−0.14; P=0.65). The average midventricular LV area shortening fraction in the healthy animals was 72.2±5.5% (versus EAM mice, 66.2±8.3%; P=0.38).
Discussion
In Vivo Detection of Inflammatory Cell Infiltration in EAM by 19 
F-CMR
To our knowledge, this preclinical study for the first time shows that in vivo CMR is able to detect inflammatory infiltrations in a model of EAM. In the beating mouse heart, the spatial and temporal resolution of the F-CMR approach thus yields information on the myocardial inflammatory cell infiltration in myocarditis. Consequently, it expands our current armamentarium to characterize myocarditis by adding this information to that on necrosis, edema, fibrosis, and function that can already be obtained by conventional CMR techniques.
The EAM model shares several similarities with human inflammatory heart disease, such as relapses, the development of interstitial fibrosis, cardiac dilation, and heart failure over time. 21 In the current in vivo and particularly in the ex vivo experiments, inflammatory infiltrates were predominantly observed in the subepicardial layers of the myocardium, which resembles the distribution of tissue damage in human viral myocarditis. 24 Similar to humans, the most prevalent location of inflammation in the mice with EAM was the base of the LV. However, in the animal model the predilection site for inflammation was found in the anterolateral wall, whereas in humans the predilection site is typically the infero-lateral wall of the LV.
Confirmation of Infiltrating Inflammatory Cells as Source of 19 F Signal in EAM
Because the PFC emulsion was injected intravenously to detect inflammation in the heart, it is crucial to determine into which cell types the PFC was incorporated in the in vivo situation. Although the immunostaining for CD45 and F4/80 was mainly detected in the subepicardial layers as was the 19 F signal, this finding in itself does not prove PFC incorporation into macrophages. Therefore, we used a PFC combined with FITC to colocalize its fluorescence within macrophages ( Figure 5) , which was not found in the controls. Finally, flow cytometry F signal can still be observed at similar locations as in the in vivo image. C, Overview of a hematoxylin-eosin (HE)-stained heart section at the same anatomic level, where the right and left ventricles (RV and LV) can be clearly discerned. D and E, Magnifications of the previous HE-stained heart section. Macrophages can be observed in a thin subepicardial layer of the RV myocardium (solid arrow). F and G, CD45 staining in the adjacent heart section confirms the presence of inflammatory bone marrow-derived cells (solid arrow) in the subepicardial layer. H and I, F4/80 staining in the adjacent heart section shows the presence of macrophages (solid arrow) at the same anatomic location. demonstrated incorporation of the PFC-FITC emulsion into F4/80+ macrophages, Gr-1+ granulocytes, CD11c+ dendritic cells, and CD11b+ monocytes. Although the EAM model is mediated by CD4+ lymphocytes, no PFC-FITC incorporation was found in this cell population. Thus, these results support the notion that intravenously administered PFC in the EAM model yield 19 F signals originating mainly from infiltrating inflammatory cells. In a model of lipopolysaccharide-induced pneumonia 14 and in inflammation after cardiac and cerebral ischemia, 17 PFC was detected predominantly in the monocyte/ macrophage and dendritic cell fractions and to a lesser extent in neutrophils, whereas T cells did not incorporate the PFC. Thus, these and other data 15, 25 are well in line with our current findings in the EAM model.
Study Limitations
The use of a surface coil in this study yielded a high detection sensitivity for 19 F, whereas it removed the option of direct fluorine quantification through comparison with an external reference phantom. For absolute quantification, a volume coil would be required in combination with a reference of known 19 F concentration. Conversely, by using array coils or compressed sensing, 26 the received signal per unit of time could possibly be amplified several times compared with that obtained by the coil used in our experiments, thus allowing for shorter acquisition times or higher detection sensitivity.
Of note, no correlation was observed between the midventricular LV area shortening fraction estimate and the disease score. This is not surprising, given that in the EAM model heart failure develops after the peak of acute inflammation, in most cases not earlier than 30 to 50 days after immunization. Nevertheless, as the area shortening fraction was calculated from a single midventricular slice and not from the entire LV, we cannot entirely exclude that a correlation would exist if function of the entire LV had been measured.
Because PFCs are inert molecules, their elimination from the body is unlikely to cause toxicity concerns. 27 However, this aspect will require additional in-depth studies in the future. At the current stage, the minimum required PFC dose for mocarditis detection by 19 F-CMR is not yet known. Lower dosages than those used in this study may still be critically enabling for monitoring inflammatory cell infiltration or responsiveness to therapy by the PFC used in this study. Furthermore, for the method to be clinically useful, further studies are needed to demonstrate the ability to detect inflammation at earlier stages of myocarditis. In particular, the lack of PFC uptake by lymphocytes might decrease the sensitivity of this approach to detect early stages of myocarditis. Disease score (a.u.) Figure 8 . Correlations of the histological disease score and quantified cardiac magnetic resonance data. For these analyses, the experimental autoimmune myocarditis (EAM) mice that received postmortem histology and perfluorocarbon (PFC) (n=7) as well as the healthy controls that received PFC (n=6, overlapping points near the origin) were used. Linear fits were added to illustrate trends. A, The fluorine-19 ( 
Clinical Perspective: Applications in Humans
In the current in vivo study, the SNR of the 19 F-positive heart regions was high (25±19) with a voxel size of 0.47×0.47×2 mm 3 acquired over 32 minutes at 9.4T. Current voxel sizes in human studies to detect, for example, small necrotic lesions in myocarditis are in the order of 2×2×8 mm 3 . Thus, with a 72× larger voxel size in humans, a similar SNR for 19 F could theoretically be obtained at 3T (instead of 9.4T) with a 7-minute acquisition. This rough estimate does not account for any improvements in pulse sequences and coil designs that may be exploited if such a 19 F-based approach were further pursued on commercial human MRI scanners. Thus, transition of this 19 F-CMR approach into the human setting seems to be in reach from a technical point of view. In addition, the PFC compounds are inert molecules and some of them have already passed safety trials in humans when used as potential plasma expanders. 27 When PFCs were used for in vitro labeling experiments, no negative effects were found on cell viability and cell function of dendritic cells 28 and polymorphonuclear neutrophils. 29 In summary, these current and other preliminary results of 19 F MRI applications for inflammation detection and the fact that the PFCs exhibit a high safety profile, [27] [28] [29] suggest a feasible and highly desirable transition of this 19 F approach into a clinical application. From a biological point of view, future studies are needed to test whether human macrophages are able to incorporate PFC in vivo in sufficient quantities to allow for noninvasive detection by 19 F-CMR. In addition, conventional 1 H anatomic images can easily be fused with the 19 F images, which allows for an exact coregistration of the 19 F signal with cardiac anatomy. Conventional 1 H CMR can be applied in the same session to assess myocardial global and regional function, cardiac remodeling, myocardial edema, perfusion, and necrosis.
Currently, the ability to detect myocarditis by conventional 1 H CMR through secondary tissue alterations, such as edema and necrosis, is clinically highly valuable. However, the prospect of being able to visualize noninvasively, quantitatively, and specifically the early-stage recruitment of immune cells into the myocardium with a 19 F-CMR approach could represent an important step toward a better understanding of the pathophysiology of myocarditis. It could also allow for early detection of the disease, and it potentially opens opportunities for treatment monitoring of myocarditis. Longitudinal studies combining 1 H-and 19 F-CMR could be used to assess the timing of inflammatory cell infiltration, development of edema and necrosis, alterations in function, and finally transition of myocarditis into various phenotypes, such as for example, dilated cardiomyopathy with local 24 or interstitial 30 fibrosis development.
Conclusions
In this study, 19 F-CMR was successfully applied in a mouse model of EAM to visualize the inflammation process of myocarditis specifically and robustly. This critically enabled an unprecedented insight into the involvement of inflammatory cells in the disease process. This approach can provide novel information on the magnitude and timing of inflammatory cell infiltration in myocarditis and may add potentially valuable information complementary to that on necrosis, edema, fibrosis, and function obtained by conventional CMR methods.
